Urigen Pharmaceuticals, Inc. (UGRP.OB) is a publicly traded company in the Unknown sector. Across all available filings, 3 corporate insiders have executed 57 transactions totaling $76.6K, demonstrating a bullish sentiment with $76.6K in net insider flow. The most recent transaction on Oct 5, 2009 involved a purchase of 10,000 shares valued at $700.
No significant insider buying has been recorded for UGRP.OB in the recent period.
No significant insider selling has been recorded for UGRP.OB in the recent period.
Based on recent SEC filings, insider sentiment for UGRP.OB is bullish with an Insider Alignment Score of 100/100 and a net flow of $76.6K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Urigen Pharmaceuticals, Inc. (UGRP.OB) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 3 insiders are actively trading UGRP.OB stock, having executed 57 transactions in the past 90 days. The most active insider is Martin E. Shmagin (Executive), who has made 26 transactions totaling $40.7K.
Get notified when executives and directors at UGRP.OB file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Oct 5, 2009 | Lowell Parsons C. | Executive | Purchase | 10,000 | $0.07 | $700 | |
| Oct 2, 2009 | Lowell Parsons C. | Executive | Purchase | 13,000 | $0.07 | $910 | |
| Oct 1, 2009 | Lowell Parsons C. | Executive | Purchase | 20,000 | $0.06 | $1.2K | |
| Oct 1, 2009 | Lowell Parsons C. | Executive | Purchase | 10,000 | $0.07 | $700 | |
| Jul 28, 2009 | Lowell Parsons C. | Executive | Purchase | 20,000 | $0.07 | $1.4K | |
| Jun 11, 2009 | E. Shmagin Martin | Executive | Purchase | 1,500 | $0.08 | $120 | |
| Jun 1, 2009 | Lowell Parsons C. | Executive | Purchase | 7,500 | $0.09 | $675 | |
| May 26, 2009 | Lowell Parsons C. | Executive | Purchase | 7,500 | $0.09 | $675 | |
| May 22, 2009 | Lowell Parsons C. | Executive | Purchase | 7,500 | $0.08 | $600 | |
| Mar 18, 2009 | E. Shmagin Martin | Executive | Purchase | 1,000 | $0.09 | $90 | |
| Mar 17, 2009 | Lowell Parsons C. | Executive | Purchase | 2,500 | $0.90 | $2.3K | |
| Mar 16, 2009 | Lowell Parsons C. | Executive | Purchase | 3,000 | $0.80 | $2.4K | |
| Mar 16, 2009 | E. Shmagin Martin | Executive | Purchase | 1,000 | $0.08 | $80 | |
| Mar 16, 2009 | E. Shmagin Martin | Executive | Purchase | 1,000 | $0.09 | $90 | |
| Mar 13, 2009 | E. Shmagin Martin | Executive | Purchase | 1,000 | $0.09 | $90 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 57 | $76.6K | 100.0% |
Insiders at Urigen Pharmaceuticals, Inc. are accumulating shares at an accelerated pace. With 3 insiders making 57 transactions totaling $76.6K in purchases versus $0 in sales, the net buying activity of $76.6K signals strong executive confidence. Martin E. Shmagin (Executive) leads the buying activity with $40.7K in transactions across all time.